IPO Premiums
IPO calendar
SDListed

Suraksha Diagnostic Limited

Bookbuilding IPO · NSE, BSE

Price band
₹420 - ₹441
Lot size
34 shares
Issue amount
₹846.25 cr
Total subscription
1.27×
Current price₹297.95
Listing price ₹438
Watch live price ↗
Opens
29 Nov 2024
Closes
3 Dec 2024
Allotment
4 Dec 2024
Listing
6 Dec 2024

Offer at a glance

Issue overview

Issue size
1,91,89,330 shares
Face value
₹2 Per Share
Minimum investment
₹14,280
Fresh issue
₹0 cr
Offer for sale
₹846.25 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,994
Issue type
Bookbuilding IPO
Shares before issue
5,20,80,758
Shares after issue
0

Lot sizes

CategoryLotsSharesAmount
Retail134₹14,994
sHNI14476₹2,09,916
bHNI672,278₹10,04,598

Share reservation

QIB28.57%
HNI21.43%
RETAIL50%

Subscription & GMP

Subscription by category

Total subscribed1.27×

Missing multiples are calculated from bids and offered shares when available.

QIBs1.74×
HNIs1.41×
HNIs 10+1.53×
HNIs 2+1.16×
Retail0.95×

GMP history

06.5131 Nov: ₹1317 Nov: ₹13
1 Nov₹1317 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL01,86,845
HNIs(10L +)06,155
HNIs (2-10L)02,343

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs0294.03
RETAIL296.19280.16
HNIs 2+42.3149.18
HNIs 10+84.62129.21

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
0100200300Mar-22 · Revenue: 225.77Mar-22 · Profit after tax: 20.82Mar-22Mar-23 · Revenue: 193.69Mar-23 · Profit after tax: 6.07Mar-23Mar-24 · Revenue: 222.26Mar-24 · Profit after tax: 23.13Mar-24Jun-24 · Revenue: 61.85Jun-24 · Profit after tax: 7.67Jun-24
RevenueProfit after tax

Key performance indicators

MetricJun-24Mar-24Mar-23
EPS1.494.431.22
ROE4.3314.094.32
ROCE6.3221.469.05
RONW4.3314.094.32
Pre IPO99.3100
Post IPO000

Values and labels as reported in the issue data.

Company information

Company profile

Suraksha Diagnostic Limited, incorporated on March 15, 2005, is a technology-driven diagnostic chain offering integrated pathology, radiology, and medical consultancy services. The company provides over 2,300 tests across multiple specialties through a network that includes a central reference laboratory, 8 satellite laboratories, and 194 customer touchpoints, comprising 48 diagnostic centers and 146 sample collection centers. Additionally, 43 diagnostic centers house 120 polyclinics staffed by over 750 doctors, providing online and offline consultations. Leveraging advanced technology such as LIMS, RIS, PACS, and ERP systems, Suraksha Diagnostic enhances operational efficiency and reduces turnaround times. The company also offers vaccination services, customized testing packages for early disease detection, and AI-driven digital pathology solutions, with all radiology reports digitally processed to enable seamless reporting across centers.

Strengths

  • Strong Market Position: Leading diagnostics chain in eastern and northeastern India with growth potential in a fragmented market.
  • Comprehensive Offerings: Integrated pathology, radiology, and medical consultancy services with a wide network of diagnostic and sample collection centers.
  • Technological Edge: Advanced clinical infrastructure with digital pathology, AI-driven diagnostics, and efficient systems including LIMS, RIS, PACS, and ERP.

Risk factors

  • Geographic Concentration: Heavy reliance on West Bengal for 95.48% of revenue makes the company vulnerable to regional disruptions affecting operations and financial performance.
  • Promoter Group Issues: Past suspension of securities of certain Promoter Group members raises reputational concerns and may complicate future capital raising.
  • Intense Competition: Operating in a competitive diagnostics industry with a modest market share (1.15–1.30% in East India) could restrict growth and profitability.

Promoters

Dr. Somnath Chatterjee

Ritu Mittal

Satish Kumar Verma

Registrar & documents

Lead manager

ICICI Securities Limited, Nuvama Wealth Management Limited, SBI Capital Markets Limited

Registered office

Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat, Kolkata 700 156, West Bengal, India

+91 33 66059750

[email protected]

Frequently Asked Questions

What is Suraksha Diagnostic IPO GMP today?

As of today, Suraksha Diagnostic IPO Grey Market Premium (GMP) is reported at +₹13 per share. Based on the upper price band of ₹441, the estimated listing price is ₹454 (+2.9% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Suraksha Diagnostic IPO?

The minimum bid lot size for Suraksha Diagnostic IPO is 34 shares. At the cut-off price of ₹441 per share, retail investors need a minimum application amount of ₹14,994 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Suraksha Diagnostic IPO allotment status be announced?

The allotment status for Suraksha Diagnostic IPO is scheduled to be finalized on 4 Dec 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Suraksha Diagnostic IPO allotment status online by PAN?

To check Suraksha Diagnostic IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Suraksha Diagnostic Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Suraksha Diagnostic IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums